Page 4 - Bioscience Inc News Today

At issue is mifepristone, part of a two-drug protocol used in medication abortions, the most common form of the procedure today. Under current Food and Drug Administration protocols, the drug can... -March 26, 2024 at 06:10 am EDT - MarketScreener

WOBURN, Mass., March 26, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. YTEN ("Yield10" or the "Company"), an agricultural bioscience company, today…

I-80 Gold 4Q Rev $25.8M; 4Q Adj Loss/Shr 7c; 4Q Gold Sales of 3,350 Oz at Realized Price of $1,996 Per Oz --- ISC Reports Record Revenue, Adjusted Ebitda for 2023; 2023 EPS C$1.39 Vs. EPS... -March 13, 2024 at 06:20 am EDT - MarketScreener

Yield10 Bioscience Inc. on Feb. 14 announced it has granted VISION Bioenergy Oilseeds LLC a global license to certain proprietary varieties of camelina sativa for the production of feedstock oil for biofuels.

WOBURN, Mass., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. YTEN ("Yield10" or the "Company"), an agricultural bioscience company, today…

/PRNewswire/ -- The "Global Market for Biofuels 2024-2035" report has been added to ResearchAndMarkets.coms offering. The biofuels market has grown...

Jill Biden announces $100 million in federal funding for women's health research, addressing underfunding and lack of awareness. ARPA-H Sprint for Women's Health aims to promote innovative solutions.

Global License of Industry-Leading Elite Herbicide Tolerant Camelina Accelerates Biofuel Feedstock Production...

Yield10 Bioscience, Inc. ("Yield10" or the "Company"), an agricultural bioscience company, and VISION Bioenergy Oilseeds, LLC ("VISION"), a U.S. agricultural company focused on commercial production of ultra-low carbon biofuel feedstock, today...

-Prioritizes Activities to Advance Omega-3 Camelina Program in 2024-Reports Completion of Contra Season Production of Omega-3 Camelina Seed in Chi...